Reports the necessity of patent protection legislation reforms for Biotech companies in the United States. Factors influencing requirement for processing patent applications; Difficulties of recruiting patent lawyers for in-house staff; Importance of personnel accessibility to company proceedings. INSETS: ...
Biotech companies in the United Kingdom outperform their European peers in securing early-stage funding but raise fewer rounds at a smaller average size than start-ups in the United States and China. Compared with European firms, UK biotechs raise less late-stage financing that wou...
Get in touch with a biotechnologist for help taking your startup forward. Kolabtree helps businesses worldwide hire freelance scientists and industry experts on demand. Our freelancers have helped companies publish research papers, develop products, analyze data, and more. It only takes a minute to...
This statistic shows the research and development spending of biotechnology companies based in selected countries for 2021 (or latest year available).
The acquisition marks recognition and power of Chinese biotech companies in the global market. As the first Chinese biotech company to be acquired by the international pharmaceutical firm, Gracell set an example for its domestic peers about how to maximize the shareholder value at an appropriate ...
Due to the ease-of-use and high image quality of this solution,in-person audits could soon become a thing of the past. Available Now The RACK virtual audit solution is available to companies in the United States, EU, UK, Australia, New Zealand, Japan, India and China. After requesting ...
biotech programs in the United States. The Chinese medical institutes will cooperate with U.S. biotech companies to license in their technologies, initiate clinical trials upon the approval of SFDA, and ultimately sell the legal drugs. Such cooperation has been normal in the Chinese market, Guo ...
Zhong said that instruments used in synthetic biology often cost at least 5 million yuan (about 690,000 U.S. dollars), which is too expensive for startups. However, companies in the innovation hub can access R&D platforms and equipment at a fraction of the market price, significantly reducin...
The three largest focus on providing services, on immunotherapies, and on brain and neuronal therapies. These together represent half of the biotech companies in Europe (Exhibit 1). In comparison, the United States focuses more on advanced-therapy medicinal products (about 20 percent...
Remedi is born from the merger of Regenera Activa and Rigenera HBW, biotech companies specialized in regenerative medicine The company works with the patented Rigenera® technology, an innovative noninvasive treatment based on autologous biological components co...